These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38850834)

  • 1. Translocator protein (TSPO) genotype does not change cerebrospinal fluid levels of glial activation, axonal and synaptic damage markers in early Alzheimer's disease.
    Gouilly D; Vrillon A; Bertrand E; Goubeaud M; Catala H; Germain J; Ainaoui N; Rafiq M; Nogueira L; Mouton-Liger F; Planton M; Salabert AS; Hitzel A; Méligne D; Jasse L; Sarton B; Silva S; Lemesle B; Péran P; Payoux P; Thalamas C; Paquet C; Pariente J
    Neuroimage Clin; 2024 May; 43():103626. PubMed ID: 38850834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort?
    Fan Z; Harold D; Pasqualetti G; Williams J; Brooks DJ; Edison P
    J Nucl Med; 2015 May; 56(5):707-13. PubMed ID: 25840980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains.
    Gui Y; Marks JD; Das S; Hyman BT; Serrano-Pozo A
    Brain Pathol; 2020 Jan; 30(1):151-164. PubMed ID: 31276244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer's disease.
    Nordengen K; Kirsebom BE; Richter G; Pålhaugen L; Gísladóttir B; Siafarikas N; Nakling A; Rongve A; Bråthen G; Grøntvedt GR; Gonzalez F; Waterloo K; Sharma K; Karikari T; Vromen EM; Tijms BM; Visser PJ; Selnes P; Kramberger MG; Winblad B; Blennow K; Fladby T
    J Neuroinflammation; 2023 Dec; 20(1):298. PubMed ID: 38093257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The translocator protein gene is associated with symptom severity and cerebral pain processing in fibromyalgia.
    Kosek E; Martinsen S; Gerdle B; Mannerkorpi K; Löfgren M; Bileviciute-Ljungar I; Fransson P; Schalling M; Ingvar M; Ernberg M; Jensen KB
    Brain Behav Immun; 2016 Nov; 58():218-227. PubMed ID: 27448744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
    Bos I; Vos S; Verhey F; Scheltens P; Teunissen C; Engelborghs S; Sleegers K; Frisoni G; Blin O; Richardson JC; Bordet R; Tsolaki M; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Lleó A; Johannsen P; Freund-Levi Y; Frölich L; Vandenberghe R; Westwood S; Dobricic V; Barkhof F; Legido-Quigley C; Bertram L; Lovestone S; Streffer J; Andreasson U; Blennow K; Zetterberg H; Visser PJ
    Alzheimers Dement; 2019 May; 15(5):644-654. PubMed ID: 30853464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels.
    Hong S; Dobricic V; Ohlei O; Bos I; Vos SJB; Prokopenko D; Tijms BM; Andreasson U; Blennow K; Vandenberghe R; Gabel S; Scheltens P; Teunissen CE; Engelborghs S; Frisoni G; Blin O; Richardson JC; Bordet R; ; Lleó A; Alcolea D; Popp J; Clark C; Peyratout G; Martinez-Lage P; Tainta M; Dobson RJB; Legido-Quigley C; Sleegers K; Van Broeckhoven C; Tanzi RE; Ten Kate M; Wittig M; Franke A; Lill CM; Barkhof F; Lovestone S; Streffer J; Zetterberg H; Visser PJ; Bertram L
    Alzheimers Dement; 2021 Oct; 17(10):1628-1640. PubMed ID: 33991015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects.
    Varrone A; Oikonen V; Forsberg A; Joutsa J; Takano A; Solin O; Haaparanta-Solin M; Nag S; Nakao R; Al-Tawil N; Wells LA; Rabiner EA; Valencia R; Schultze-Mosgau M; Thiele A; Vollmer S; Dyrks T; Lehmann L; Heinrich T; Hoffmann A; Nordberg A; Halldin C; Rinne JO
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):438-46. PubMed ID: 25412766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocator Protein (18 kDa) Polymorphism (rs6971) in the Korean Population.
    Lee H; Noh Y; Kim WR; Seo HE; Park HM
    Dement Neurocogn Disord; 2022 Apr; 21(2):71-78. PubMed ID: 35585910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions.
    Teitsdottir UD; Jonsdottir MK; Lund SH; Darreh-Shori T; Snaedal J; Petersen PH
    Alzheimers Res Ther; 2020 Aug; 12(1):92. PubMed ID: 32753068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer's disease.
    Kivisäkk P; Carlyle BC; Sweeney T; Quinn JP; Ramirez CE; Trombetta BA; Mendes M; Brock M; Rubel C; Czerkowicz J; Graham D; Arnold SE
    Alzheimers Res Ther; 2022 Apr; 14(1):58. PubMed ID: 35461266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias.
    Antonell A; Tort-Merino A; Ríos J; Balasa M; Borrego-Écija S; Auge JM; Muñoz-García C; Bosch B; Falgàs N; Rami L; Ramos-Campoy O; Blennow K; Zetterberg H; Molinuevo JL; Lladó A; Sánchez-Valle R
    Alzheimers Dement; 2020 Feb; 16(2):262-272. PubMed ID: 31668967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.
    Janelidze S; Hertze J; Zetterberg H; Landqvist Waldö M; Santillo A; Blennow K; Hansson O
    Ann Clin Transl Neurol; 2016 Jan; 3(1):12-20. PubMed ID: 26783546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging.
    Hamelin L; Lagarde J; Dorothée G; Leroy C; Labit M; Comley RA; de Souza LC; Corne H; Dauphinot L; Bertoux M; Dubois B; Gervais P; Colliot O; Potier MC; Bottlaender M; Sarazin M;
    Brain; 2016 Apr; 139(Pt 4):1252-64. PubMed ID: 26984188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Alzheimer's disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein.
    Ji B; Ono M; Yamasaki T; Fujinaga M; Zhang MR; Seki C; Aoki I; Kito S; Sawada M; Suhara T; Sahara N; Higuchi M
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):2076-2089. PubMed ID: 33557690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial activation and inflammation along the Alzheimer's disease continuum.
    Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
    J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles.
    Wesenhagen KEJ; Tijms BM; Boonkamp L; Hoede PL; Goossens J; Dewit N; Scheltens P; Vanmechelen E; Visser PJ; Teunissen CE
    Alzheimers Res Ther; 2022 Jul; 14(1):95. PubMed ID: 35841015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationships between Cerebrospinal Fluid Glial (CXCL12, CX3CL, YKL-40) and Synaptic Biomarkers (Ng, NPTXR) in Early Alzheimer's Disease.
    Kulczyńska-Przybik A; Dulewicz M; Doroszkiewicz J; Borawska R; Słowik A; Zetterberg H; Hanrieder J; Blennow K; Mroczko B
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 11C-ER176, a Radioligand for 18-kDa Translocator Protein, Has Adequate Sensitivity to Robustly Image All Three Affinity Genotypes in Human Brain.
    Ikawa M; Lohith TG; Shrestha S; Telu S; Zoghbi SS; Castellano S; Taliani S; Da Settimo F; Fujita M; Pike VW; Innis RB;
    J Nucl Med; 2017 Feb; 58(2):320-325. PubMed ID: 27856631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.